Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development

The central nervous system (CNS) has, among all organ systems in the human body, the highest failure rate of traditional small-molecule drug development, ranging from 80–100% depending on the area of disease research. This has led to widespread abandonment by the pharmaceutical industry of research...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Meenakshi, Farias Quipildor, Gabriela, Ehrlich, Michelle E., Salton, Stephen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688574/
https://www.ncbi.nlm.nih.gov/pubmed/36429060
http://dx.doi.org/10.3390/cells11223629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688574/
https://www.ncbi.nlm.nih.gov/pubmed/36429060
http://dx.doi.org/10.3390/cells11223629

Ejemplares similares